Gordon Naylor
Fortuna: 4 M $ al 30/06/2026
Fortuna: 4 M $ al 30/06/2026
Gordon Naylor is Chief Executive Officer, MD & Director at CSL Ltd. since 2026.
Mr. Naylor is Independent Non-Executive Director at Orica Ltd. since 2022.
Mr. Naylor is Director at Seqirus Holdings UK Ltd. since 2015.
Mr. Naylor is Senior Vice President & General Manager at CSL Plasma, Inc. Former roles include Non-Executive Chairman at Medical Developments International Ltd. from 2020 to 2025, Chief Financial Officer at CSL Ltd. from 2010 to 2016, EVP-Plasma, Supply Chain & Information Systems at CSL Behring LLC, and President at Seqirus UK Ltd. from 2015 to 2019.
Education includes an MBA from Melbourne Business School and undergraduate studies at the University of Melbourne.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CSL LIMITED 0,01 % | 26/05/2026 | 40.819 ( 0,01 % ) | 3 M $ | 30/06/2026 |
| 15/08/2025 | 1.045.113 ( 0,93 % ) | 286 006 $ | 30/06/2026 | |
| 30/09/2025 | 16.394 ( 0 % ) | 268 952 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ORICA LIMITED | Director/Miembro de la Junta | 01/04/2022 |
| CSL LIMITED | Director Ejecutivo | 11/02/2026 |
CSL Plasma, Inc.
CSL Plasma, Inc. Medical/Nursing ServicesHealth Services Collects blood donations | Corporate Officer/Principal | - |
Seqirus Holdings UK Ltd.
Seqirus Holdings UK Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Director/Miembro de la Junta | 29/05/2015 |
| Empresas | Cargo | Fin |
|---|---|---|
| MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Presidente | 01/12/2025 |
Seqirus UK Ltd.
Seqirus UK Ltd. Pharmaceuticals: MajorHealth Technology Develops and delivers therapies for people living with conditions in the immunology, hematology, cardiovascular, metabolic, respiratory & transplant therapeutic areas | Presidente | 01/06/2019 |
| CSL LIMITED | Director Financiero/CFO | 02/01/2016 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Medical Developments International Ltd.
Medical Developments International Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical drugs & medical equipment | Health Technology |
Melbourne Business School
Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orica Ltd.
Orica Ltd. Industrial SpecialtiesProcess Industries Manufactures and distributes commercial blasting systems & mining and tunneling support systems to the mining and infrastructure markets | Process Industries |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
CSL Plasma, Inc.
CSL Plasma, Inc. Medical/Nursing ServicesHealth Services Collects blood donations | Health Services |
Seqirus UK Ltd.
Seqirus UK Ltd. Pharmaceuticals: MajorHealth Technology Develops and delivers therapies for people living with conditions in the immunology, hematology, cardiovascular, metabolic, respiratory & transplant therapeutic areas | Health Technology |
Seqirus Holdings UK Ltd.
Seqirus Holdings UK Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.